Kawata Manabu, Teramura Takeshi, Ordoukhanian Philip, Head Steven R, Natarajan Padmaja, Sundaresan Aishwarya, Olmer Merissa, Asahara Hiroshi, Lotz Martin K
Department of Molecular Medicine, Scripps Research, La Jolla, California, USA.
Division of Cell Biology for Regenerative Medicine, Institute of Advanced Clinical Medicine, Kindai University, Osaka-Sayama, Osaka, Japan.
Ann Rheum Dis. 2022 Jul 12;81(8):1179-1188. doi: 10.1136/annrheumdis-2021-221867.
Analysing expression patterns of Krüppel-like factor (KLF) transcription factors in normal and osteoarthritis (OA) human cartilage, and determining functions and mechanisms of KLF4 and KLF2 in joint homoeostasis and OA pathogenesis.
Experimental approaches included human joint tissues cells, transgenic mice and mouse OA model with viral KLF4 gene delivery to demonstrate therapeutic benefit in structure and pain improvement. Mechanistic studies applied global gene expression analysis and chromatin immunoprecipitation sequencing (ChIP-seq).
Several KLF genes were significantly decreased in OA cartilage. Among them, KLF4 and KLF2 were strong inducers of cartilage collagen genes and Proteoglycan-4. Cartilage-specific deletion of in mature mice aggravated severity of experimental OA. Transduction of human chondrocytes with Adenovirus (Ad) expressing KLF4 or KLF2 enhanced expression of major cartilage extracellular matrix (ECM) genes and SRY-box transcription factor-9, and suppressed mediators of inflammation and ECM-degrading enzymes. Ad-KLF4 and Ad-KLF2 enhanced similar protective functions in meniscus cells and synoviocytes, and promoted chondrocytic differentiation of human mesenchymal stem cells. Viral KLF4 delivery into mouse knees reduced severity of OA-associated changes in cartilage, meniscus and synovium, and improved pain behaviours. ChIP-seq analysis suggested that KLF4 directly bound cartilage signature genes. Ras-related protein-1 signalling was the most enriched pathway in KLF4-transduced cells, and its signalling axis was involved in upregulating cartilage ECM genes by KLF4 and KLF2.
KLF4 and KLF2 may be central transcription factors that increase protective and regenerative functions in joint tissue cells, suggesting that KLF gene transfer or molecules upregulating KLFs are therapeutic candidates for OA.
分析Krüppel样因子(KLF)转录因子在正常及骨关节炎(OA)人软骨中的表达模式,并确定KLF4和KLF2在关节稳态及OA发病机制中的功能和机制。
实验方法包括人关节组织细胞、转基因小鼠以及通过病毒KLF4基因递送构建的小鼠OA模型,以证明其在结构改善和疼痛缓解方面的治疗益处。机制研究采用全基因表达分析和染色质免疫沉淀测序(ChIP-seq)。
几种KLF基因在OA软骨中显著降低。其中,KLF4和KLF2是软骨胶原基因和蛋白聚糖-4的强效诱导剂。成熟小鼠软骨特异性缺失会加重实验性OA的严重程度。用表达KLF4或KLF2的腺病毒(Ad)转导人软骨细胞可增强主要软骨细胞外基质(ECM)基因和SRY盒转录因子-9的表达,并抑制炎症介质和ECM降解酶。Ad-KLF4和Ad-KLF2在半月板细胞和滑膜细胞中增强了类似的保护功能,并促进了人间充质干细胞的软骨细胞分化。将病毒KLF4递送至小鼠膝关节可减轻软骨、半月板和滑膜中OA相关变化的严重程度,并改善疼痛行为。ChIP-seq分析表明KLF4直接结合软骨特征基因。Ras相关蛋白-1信号通路是KLF4转导细胞中最富集的通路,其信号轴参与了KLF4和KLF2上调软骨ECM基因的过程。
KLF4和KLF2可能是增强关节组织细胞保护和再生功能的核心转录因子,这表明KLF基因转移或上调KLFs的分子可能是OA的治疗候选物。